Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo

Journal of Infectious Diseases

Volumn 179, Issue 5, 1999, Pages 1301-1304

  Gaviria, J Milton ^a   Van Burik, Jo Anne H ^a   Dale, David C ^a   Root, Richard K ^a   Liles, W Conrad ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; FUNGICIDAL ACTIVITY; FUNGUS HYPHAE; FUSARIUM SOLANI; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOMODULATION; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; FUSARIUM; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MIDDLE AGED; NEUTROPHILS;

EID: 0033041655     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314728     Document Type: Article

References (15)

1. 1. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993;328:1323-32.
2. 2. Liles WC, Dale DC. Current approach to the management of neutropenia. J Intensive Care Med 1995;10:283-93.
3. 3. van Burik J-AH, Leisenring E, Myerson D, et al. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. Medicine 1998;77:246-54.
4. 4. Malech HL, Gallin JI. Neutrophils in human diseases. N Engl J Med 1987;317:687-94.
5. 5. Diamond RD, Clark RA. Damage to Aspergillus fumigatus and Rhizupus oryzae hyphae by oxidative and nonoxidative microbial products of human neutrophils in vitro. Infect Immun 1982;38:487-95.
6. 6. Dale DC, Liles WC, Summer WR, Nelson S. Granulocyte colony-stimulating factor (G-CSF): roles and relationships in infectious diseases. J Infect Dis 1995;172:1061-75.
7. 7. Liles WC, Huang JE, van Burik J-AH, Bowden RA, Dale DC. Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens. J Infect Dis 1997;175:1012-5.
8. 8. Vecchiarelli A, Monari C, Baldelli F, et al. Beneficial effect of recombinant human granulocyte colony-stimulating factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDS. J Infect Dis 1995;171:1448-54.
9. 9. Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ. Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun 1993;61:1185-93.
10. 10. Roilides E, Holmes A, Blake C, Pizzo PA, Walsh TJ. Impairment of neutrophil antifungal activity against hyphae of Aspergillus fumigatus in children infected with human immunodeficiency virus. J Infect Dis 1993;167: 905-11.
11. 11. Bober LA, Grace MJ, Pugliese-Silvo C, et al. The effect of GM-CSF and G-CSF on human neutrophil function. Immunopharmacology 1995;29: 111-9.
12. 12. Roilides E, Holmes A, Blake C, Pizzo PA, Walsh TJ. Effects of granulocyte colony-stimulating factor and interferon-γ on antifungal activity of human polymorphonuclear neutrophils against pseudohyphae of different medically important Candida species. J Leukoc Biol 1995;57:651-6.
13. 13. Dale DC, Liles WC, Price TH. Renewed interest in granulocyte transfusion therapy. Br J Haematol 1997;98:497-501.
14. 14. Dale DC, Liles WC, Llewellyn C, Rodger E, Price TH. Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte colony-stimulating factor (G-CSF) and dexamethasone. Transfusion 1998;38:713-21.
15. 15. Meshulam T, Levitz SM, Christin L, Diamond RD. A simplified new assay for assessment of fungal damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT). J Infect Dis 1995;172:1153-6.